Orasure Technologies Inc.

NASDAQ:OSUR  
10.89
-0.09 (-0.82%)
Products

Orasure Technologies Submits Covid-19 Rapid Antigen Prescription Home Self-Test And Professional Test To FDA For Emergency Use Authorization

Published: 03/30/2021 12:34 GMT
Orasure Technologies Inc. (OSUR) - Orasure Technologies Submits Covid-19 Rapid Antigen Prescription Home Self-test and Professional Test to FDA for Emergency Use Authorization.